You just read:

Nuvo Pharmaceuticals™ Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial for Treatment of Acute Ankle Sprains

News provided by

Nuvo Pharmaceuticals Inc.

17 Oct, 2016, 07:30 ET